Moxifloxacin Ophthalmic
Moxifloxacin Ophthalmic is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Steroids and Cross-linking for Ulcer Treatment
Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis
A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery
Clinical Trials (6)
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Steroids and Cross-linking for Ulcer Treatment
Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis
A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6